Current Liabilities
Accounts Payable
Kailera Therapeutics Accounts Payable decreased by 5.8% to $7.10M in Q1 2026 compared to the prior quarter.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2025
Last reportedQ1 2026May 26, 2026
How to read this metric
An increase can signal improved cash management or extended payment terms, while a decrease may indicate faster payments to suppliers or reduced purchasing activity.
Detailed definition
This represents the short-term obligations owed to suppliers and vendors for goods and services received on credit. It i...
Peer comparison
Standard current liability for all companies; comparable across industries based on days payable outstanding.
Metric ID:
accounts_payableHistorical Data
3 periods
| Q1 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|
| Value | $645.00K | $7.53M | $7.10M |
| QoQ Change | — | >999% | -5.8% |
| YoY Change | — | — | >999% |
Range$645.00K – $7.53M
Avg YoY Growth>999%
Median YoY Growth>999%
Accounts Payable at Other Companies
Frequently Asked Questions
- What is Kailera Therapeutics 's accounts payable?
- Kailera Therapeutics (KLRA) reported accounts payable of $7.10M in Q1 2026.
- What does accounts payable mean?
- Money the company owes to its suppliers for goods or services.